Drug Type AAV based gene therapy |
Synonyms JB 152, JB152 |
Target |
Action inhibitors |
Mechanism α-glucosidase inhibitors(Acidic alpha-glucosidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | United States | 01 Apr 2026 |





